52-week Open Label Safety-Tolerability Study
Clinical trial NCT07369154 · RECRUITING
Trial details
- NCT number
- NCT07369154
- Sponsor
- LB Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-23
- Primary completion
- 2028-12-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.